Episode
HER2-Positive Gastrointestinal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
- Published
- Apr 8, 2026
- Duration seconds
- 945
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/her2-positive-gastrointestinal-cancers-microlearning-activity-3-proceedings-from-a-session-held-adjunct-to-the-2026-asco-gi-cancers-symposium/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/her2-positive-gastrointestinal-cancers-microlearning-activity-3-proceedings-from-a-session-held-adjunct-to-the-2026-asco-gi-cancers-symposium.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr Haley Ellis from Harvard Medical School in Boston, Massachusetts, Prof Eric Van Cutsem from University Hospitals Leuven in Belgium, Dr Zev Wainberg from UCLA School of Medicine in Los Angeles, California, and moderator Dr Lionel A Kankeu Fonkoua from Mayo Clinic in Rochester, Minnesota, discuss recent data surrounding the management of HER2-positive GI cancers, alongside their perspectives on its clinical application and management. CME information and select publications here .